Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Toxicological evaluation of carcinogenicity of the pyrethroid imiprothrin in rats and mice.

Yamada T, Asano H, Miyata K, Rhomberg LR, Haseman JK, Greaves P, Greim H, Berry C, Cohen SM.

Regul Toxicol Pharmacol. 2019 Jul;105:1-14. doi: 10.1016/j.yrtph.2019.03.012. Epub 2019 Mar 21.

PMID:
30905765
2.

A bounding quantitative cancer risk assessment for occupational exposures to asphalt emissions during road paving operations.

Rhomberg LR, Mayfield DB, Prueitt RL, Rice JW.

Crit Rev Toxicol. 2018 Oct;48(9):713-737. doi: 10.1080/10408444.2018.1528208. Epub 2018 Dec 27.

PMID:
30590972
3.

Letter to the editor re: Guyton et al. (2018), 'Application of the key characteristics of carcinogens in cancer hazard identification'.

Goodman JE, Lynch HN, Rhomberg LR.

Carcinogenesis. 2018 Jul 30;39(8):1089-1090. doi: 10.1093/carcin/bgy066. No abstract available.

PMID:
29982454
4.

Corrigendum to "Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data" Environmental International 106 :178-206.

Lynch HN, Zu K, Kennedy EM, Lam T, Liu X, Pizzurro DM, Loftus CT, Rhomberg LR.

Environ Int. 2017 Dec;109:195-196. doi: 10.1016/j.envint.2017.10.004. No abstract available.

PMID:
29078863
5.

Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.

Lynch HN, Zu K, Kennedy EM, Lam T, Liu X, Pizzurro DM, Loftus CT, Rhomberg LR.

Environ Int. 2017 Sep;106:178-206. doi: 10.1016/j.envint.2017.04.008. Epub 2017 Jun 16. Erratum in: Environ Int. 2017 Dec;109 :195-196.

PMID:
28625818
6.

Systematic comparison of study quality criteria.

Lynch HN, Goodman JE, Tabony JA, Rhomberg LR.

Regul Toxicol Pharmacol. 2016 Apr;76:187-98. doi: 10.1016/j.yrtph.2015.12.017. Epub 2015 Dec 29.

7.

Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014).

Lamb JC 4th, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL.

Regul Toxicol Pharmacol. 2015 Dec;73(3):754-7. doi: 10.1016/j.yrtph.2015.10.029. Epub 2015 Nov 10.

PMID:
26550933
8.

Quantitative cancer risk assessment for occupational exposures to asphalt fumes during built-up roofing asphalt (BURA) operations.

Rhomberg LR, Mayfield DB, Goodman JE, Butler EL, Nascarella MA, Williams DR.

Crit Rev Toxicol. 2015;45(10):873-918. doi: 10.3109/10408444.2015.1094450. Epub 2015 Oct 29. Review.

PMID:
26515283
9.

Contrasting directions and directives on hazard identification for formaldehyde carcinogenicity.

Rhomberg LR.

Regul Toxicol Pharmacol. 2015 Dec;73(3):829-33. doi: 10.1016/j.yrtph.2015.10.012. Epub 2015 Oct 19. No abstract available.

PMID:
26493002
10.

Hypothesis-based weight-of-evidence evaluation and risk assessment for naphthalene carcinogenesis.

Bailey LA, Nascarella MA, Kerper LE, Rhomberg LR.

Crit Rev Toxicol. 2016;46(1):1-42. doi: 10.3109/10408444.2015.1061477. Epub 2015 Sep 7. Review.

11.

Are the elements of the proposed ozone National Ambient Air Quality Standards informed by the best available science?

Goodman JE, Sax SN, Lange S, Rhomberg LR.

Regul Toxicol Pharmacol. 2015 Jun;72(1):134-40. doi: 10.1016/j.yrtph.2015.04.001. Epub 2015 Apr 6.

PMID:
25857292
12.

Mechanisms of action for arsenic in cardiovascular toxicity and implications for risk assessment.

Sidhu MS, Desai KP, Lynch HN, Rhomberg LR, Beck BD, Venditti FJ.

Toxicology. 2015 May 4;331:78-99. doi: 10.1016/j.tox.2015.02.008. Epub 2015 Mar 11. Review.

PMID:
25771173
13.

Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012.

Lamb JC 4th, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL.

Regul Toxicol Pharmacol. 2014 Jun;69(1):22-40. doi: 10.1016/j.yrtph.2014.02.002. Epub 2014 Feb 13. Review.

14.

Strengthening the foundation of next generation risk assessment.

Goodman JE, Boyce CP, Pizzurro DM, Rhomberg LR.

Regul Toxicol Pharmacol. 2014 Feb;68(1):160-70. doi: 10.1016/j.yrtph.2013.12.002. Epub 2013 Dec 14.

PMID:
24342233
15.

Evaluation of the causal framework used for setting national ambient air quality standards.

Goodman JE, Prueitt RL, Sax SN, Bailey LA, Rhomberg LR.

Crit Rev Toxicol. 2013 Nov;43(10):829-49. doi: 10.3109/10408444.2013.837864. Epub 2013 Oct 3. Review.

PMID:
24090029
16.

A survey of frameworks for best practices in weight-of-evidence analyses.

Rhomberg LR, Goodman JE, Bailey LA, Prueitt RL, Beck NB, Bevan C, Honeycutt M, Kaminski NE, Paoli G, Pottenger LH, Scherer RW, Wise KC, Becker RA.

Crit Rev Toxicol. 2013 Oct;43(9):753-84. doi: 10.3109/10408444.2013.832727. Review.

PMID:
24040995
17.

Incorporating Low-dose Epidemiology Data in a Chlorpyrifos Risk Assessment.

Goodman JE, Prueitt RL, Rhomberg LR.

Dose Response. 2012 Jul 30;11(2):207-19. doi: 10.2203/doseresponse.12022.Goodman. Print 2013.

18.

Hypothesis-based weight-of-evidence evaluation of the human carcinogenicity of toluene diisocyanate.

Prueitt RL, Rhomberg LR, Goodman JE.

Crit Rev Toxicol. 2013 May;43(5):391-435. doi: 10.3109/10408444.2013.790877. Epub 2013 May 15. Review.

PMID:
23675773
19.

Hypothesis-based weight-of-evidence evaluation of methyl methacrylate olfactory effects in humans and derivation of an occupational exposure level.

Pemberton M, Bailey LA, Rhomberg LR.

Regul Toxicol Pharmacol. 2013 Jul;66(2):217-33. doi: 10.1016/j.yrtph.2013.04.001. Epub 2013 Apr 11.

20.
21.

Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?

Rhomberg LR, Goodman JE.

Regul Toxicol Pharmacol. 2012 Oct;64(1):130-3. doi: 10.1016/j.yrtph.2012.06.015. Epub 2012 Jun 27.

22.

A critique of the European Commission document, "State of the Art Assessment of Endocrine Disrupters".

Rhomberg LR, Goodman JE, Foster WG, Borgert CJ, Van Der Kraak G.

Crit Rev Toxicol. 2012 Jul;42(6):465-73. doi: 10.3109/10408444.2012.690367. Epub 2012 May 26. Review.

23.

Hypothesis-Based Weight-of-Evidence evaluation of methanol as a human carcinogen.

Bailey LA, Prueitt RL, Rhomberg LR.

Regul Toxicol Pharmacol. 2012 Mar;62(2):278-91. doi: 10.1016/j.yrtph.2011.11.015. Epub 2011 Dec 7.

PMID:
22166730
24.

Hypothesis-based weight-of-evidence evaluation of the neurodevelopmental effects of chlorpyrifos.

Prueitt RL, Goodman JE, Bailey LA, Rhomberg LR.

Crit Rev Toxicol. 2011 Nov;41(10):822-903. doi: 10.3109/10408444.2011.616877. Review.

PMID:
22085162
25.

Measurement error in environmental epidemiology and the shape of exposure-response curves.

Rhomberg LR, Chandalia JK, Long CM, Goodman JE.

Crit Rev Toxicol. 2011 Sep;41(8):651-71. doi: 10.3109/10408444.2011.563420. Review.

PMID:
21823979
26.

Practical Risk Assessment and Management Issues Arising were we to Adopt Low-Dose Linearity for all Endpoints.

Rhomberg LR.

Dose Response. 2011;9(2):144-57. doi: 10.2203/dose-response.10-023.Rhomberg. Epub 2010 Sep 10.

27.

Is exposure to formaldehyde in air causally associated with leukemia?--A hypothesis-based weight-of-evidence analysis.

Rhomberg LR, Bailey LA, Goodman JE, Hamade AK, Mayfield D.

Crit Rev Toxicol. 2011 Aug;41(7):555-621. doi: 10.3109/10408444.2011.560140. Epub 2011 Jun 2.

28.

Linear low-dose extrapolation for noncancer heath effects is the exception, not the rule.

Rhomberg LR, Goodman JE, Haber LT, Dourson M, Andersen ME, Klaunig JE, Meek B, Price PS, McClellan RO, Cohen SM.

Crit Rev Toxicol. 2011 Jan;41(1):1-19. doi: 10.3109/10408444.2010.536524. Review.

29.
30.

Toxicity testing in the 21st century: how will it affect risk assessment?

Rhomberg LR.

J Toxicol Environ Health B Crit Rev. 2010 Feb;13(2-4):361-75. doi: 10.1080/10937404.2010.483951.

PMID:
20574908
31.

Uncertainty factor conundrums: what lessons should we draw?

Rhomberg LR.

Risk Anal. 2010 Mar;30(3):349-52; author reply 353. doi: 10.1111/j.1539-6924.2010.01366.x. Review. No abstract available.

PMID:
20487393
32.

Weight-of-evidence analysis of human exposures to dioxins and dioxin-like compounds and associations with thyroid hormone levels during early development.

Goodman JE, Kerper LE, Boyce CP, Prueitt RL, Rhomberg LR.

Regul Toxicol Pharmacol. 2010 Oct;58(1):79-99. doi: 10.1016/j.yrtph.2010.04.008. Epub 2010 Apr 21. Review.

PMID:
20416351
33.

Linear low-dose extrapolation for noncancer responses is not generally appropriate.

Rhomberg LR.

Environ Health Perspect. 2009 Apr;117(4):A141-2; author reply A142-3. doi: 10.1289/ehp.0800329. No abstract available.

34.

Risk assessment in the 21st century: changes wrought by changing science.

Rhomberg LR.

Risk Anal. 2009 Apr;29(4):488-9; discussion 492-7. doi: 10.1111/j.1539-6924.2008.01169.x. Epub 2008 Dec 22. No abstract available.

PMID:
19144066
35.

A margin-of-exposure approach to assessment of noncancer risks of dioxins based on human exposure and response data.

Aylward LL, Goodman JE, Charnley G, Rhomberg LR.

Environ Health Perspect. 2008 Oct;116(10):1344-51. doi: 10.1289/ehp.11514. Epub 2008 Jun 16.

36.

Weight-of-evidence evaluation of reproductive and developmental effects of low doses of bisphenol A.

Goodman JE, Witorsch RJ, McConnell EE, Sipes IG, Slayton TM, Yu CJ, Franz AM, Rhomberg LR.

Crit Rev Toxicol. 2009;39(1):1-75. doi: 10.3109/10408440903279946. Review.

PMID:
18923974
37.

CERHR conclusions would have been strengthened by a more explicit weight-of-evidence analysis.

Rhomberg LR, Goodman JE.

Birth Defects Res B Dev Reprod Toxicol. 2008 Jun;83(3):155-6. doi: 10.1002/bdrb.20161. No abstract available.

PMID:
18570261
38.

Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results.

Goodman JE, Gaylor D, Beyer LA, Rhomberg LR, Beck BD.

Regul Toxicol Pharmacol. 2008 Apr;50(3):273-84. doi: 10.1016/j.yrtph.2007.12.005. Epub 2007 Dec 27. Review.

PMID:
18241965
39.

Comment on "Residential and biological exposure assessment of chemicals from a wood treatment plant" by James Dahlgren et al. [Chemosphere 67(9) (2007) S279-S285].

Rhomberg LR, Bowers TS, Beyer LA, Goodman JE.

Chemosphere. 2008 Feb;70(9):1730-3; author reply 1734-6. Epub 2007 Nov 5. No abstract available.

PMID:
17980901
40.

Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.

Rhomberg LR, Baetcke K, Blancato J, Bus J, Cohen S, Conolly R, Dixit R, Doe J, Ekelman K, Fenner-Crisp P, Harvey P, Hattis D, Jacobs A, Jacobson-Kram D, Lewandowski T, Liteplo R, Pelkonen O, Rice J, Somers D, Turturro A, West W, Olin S.

Crit Rev Toxicol. 2007;37(9):729-837. Review.

PMID:
17957539
41.

An updated weight of the evidence evaluation of reproductive and developmental effects of low doses of bisphenol A.

Goodman JE, McConnell EE, Sipes IG, Witorsch RJ, Slayton TM, Yu CJ, Lewis AS, Rhomberg LR.

Crit Rev Toxicol. 2006 May;36(5):387-457. Review.

PMID:
16954066
42.

A proposed methodology for selecting a trichloroethylene inhalation unit risk value for use in risk assessment.

Lewandowski TA, Rhomberg LR.

Regul Toxicol Pharmacol. 2005 Feb;41(1):39-54. Epub 2004 Dec 10. Review.

PMID:
15649826
43.

Seeking optimal design for animal bioassay studies.

Rhomberg LR.

Toxicol Sci. 2005 Mar;84(1):1-3. No abstract available.

PMID:
15635148
44.

Reproductive and developmental risks from ethylene oxide: a probabilistic characterization of possible regulatory thresholds.

Evans JS, Rhomberg LR, Williams PL, Wilson AM, Baird SJ.

Risk Anal. 2001 Aug;21(4):697-717.

PMID:
11726021
45.

Risk characterization of the potential for human health impact from environmental concentrations of endocrine modulators.

Rhomberg LR.

Nutrition. 2000 Jul-Aug;16(7-8):551-4. Review. No abstract available.

PMID:
10906552
46.

Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.

Rhomberg LR.

Environ Health Perspect. 2000 May;108 Suppl 2:343-58. Review.

47.
48.

Physiological parameter values for physiologically based pharmacokinetic models.

Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP.

Toxicol Ind Health. 1997 Jul-Aug;13(4):407-84. Review. No abstract available.

PMID:
9249929
49.

Carcinogens and human health: Part 3.

Cogliano VJ, Farland WH, Preuss PW, Wiltse JA, Rhomberg LR, Chen CW, Mass MJ, Nosnow S, White PD, Parker JC, et al.

Science. 1991 Feb 8;251(4994):606-8. No abstract available.

PMID:
1992511

Supplemental Content

Loading ...
Support Center